Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal cell carcinomas

Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal cell carcinomas

US Patent 7632496 · Granted Dec 15, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Test system and method with a thermally isolated hollow body inside an over the 2021
Over-the-air test system as well as method for measuring the over-the-air perfor2020
Over-the-air measurement chamber and over-the-air measurement method2019
Refrigerated sales furniture2017
Hybridoma cell line G250 and its use for producing monoclonal antibodies2017
Hybridoma cell line G250 and its use for producing monoclonal antibodies2017
Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as ren2014
Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as ren2014
Coaxial plug for connecting to a BNC coaxial socket2011
Adjuvant theraphy of G250-expressing tumors2010
Method and device for detecting a given material in an object using electromagne2006
Method for image management of X-ray images2004